Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation
- PMID: 29675436
- PMCID: PMC5838472
- DOI: 10.1155/2018/6345857
Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation
Abstract
Numerous studies have examined the pathogenesis of osteoporosis. The causes of osteoporosis include endocrine factors, nutritional status, genetic factors, physical factors, and immune factors. Recent osteoimmunology studies demonstrated that the immune system and immune factors play important regulatory roles in the occurrence of osteoporosis, and people should pay more attention to the relationship between immunity and osteoporosis. Immune and bone cells are located in the bone marrow and share numerous regulatory molecules, signaling molecules, and transcription factors. Abnormal activation of the immune system alters the balance between osteoblasts and osteoclasts, which results in an imbalance of bone remodeling and osteoporosis. The incidence of osteoporosis is also increasing with the aging of China's population, and traditional Chinese medicine has played a vital role in the prevention and treatment of osteoporosis for centuries. Chinese medicinal plants possess unique advantages in the regulation of the immune system and the relationships between osteoporosis and the immune system. In this review, we provide a general overview of Chinese medicinal plants in the prevention and treatment of osteoporosis, focusing on immunological aspects.
Similar articles
-
The Role of Traditional Chinese Medicines in the Treatment of Osteoporosis.Am J Chin Med. 2024;52(4):949-986. doi: 10.1142/S0192415X24500393. Epub 2024 Jun 14. Am J Chin Med. 2024. PMID: 38879748 Review.
-
Osteoimmunology.Int Arch Allergy Immunol. 2007;143(1):31-48. doi: 10.1159/000098223. Epub 2006 Dec 22. Int Arch Allergy Immunol. 2007. PMID: 17191007 Review.
-
Osteoblasts and osteoclasts in bone remodeling and inflammation.Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):325-8. doi: 10.2174/1568010054022015. Curr Drug Targets Inflamm Allergy. 2005. PMID: 16101541 Review.
-
The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.Front Immunol. 2023 Jul 5;14:1222129. doi: 10.3389/fimmu.2023.1222129. eCollection 2023. Front Immunol. 2023. PMID: 37475866 Free PMC article. Review.
-
The pathophysiology of immunoporosis: innovative therapeutic targets.Inflamm Res. 2021 Aug;70(8):859-875. doi: 10.1007/s00011-021-01484-9. Epub 2021 Jul 16. Inflamm Res. 2021. PMID: 34272579 Review.
Cited by
-
A correlative studies between osteoporosis and blood cell composition: Implications for auxiliary diagnosis of osteoporosis.Medicine (Baltimore). 2020 Jun 26;99(26):e20864. doi: 10.1097/MD.0000000000020864. Medicine (Baltimore). 2020. PMID: 32590789 Free PMC article.
-
Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.Sci Rep. 2019 May 6;9(1):6991. doi: 10.1038/s41598-019-43518-7. Sci Rep. 2019. PMID: 31061445 Free PMC article.
-
Efficacy and safety of Zuogui Pill in treating osteoporosis: Study protocol of a systematic review.Medicine (Baltimore). 2019 Feb;98(8):e13936. doi: 10.1097/MD.0000000000013936. Medicine (Baltimore). 2019. PMID: 30813123 Free PMC article.
-
Novel Anti-Viral Properties of the Herbal Extract of Davallia mariesii against Influenza A Virus.Viruses. 2024 Mar 28;16(4):523. doi: 10.3390/v16040523. Viruses. 2024. PMID: 38675866 Free PMC article.
-
Mediating oxidative stress through the Palbociclib/miR-141-3p/STAT4 axis in osteoporosis: a bioinformatics and experimental validation study.Sci Rep. 2023 Nov 10;13(1):19560. doi: 10.1038/s41598-023-46813-6. Sci Rep. 2023. PMID: 37949959 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical